K

Kronos Bio

97 employees

Kronos Bio focuses on the research and development of first-in-class therapies that modulate historically recalcitrant cancer.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Chemical
Therapeutics

Date founded

2017

Funding rounds raised

Total raised

$155M

from 21 investors over 21 rounds

K

Kronos Bio raised $155M on August 25, 2020

Investors: Nextech Invest, Omega Funds, Woodline Partners LP, Polaris Partners, T. Rowe Price, Vida Ventures, LLC, GV, Surveyor Capital, Perceptive Advisors and The Invus Group

K

Kronos Bio raised $105M on July 18, 2019

Investors: Nextech Invest, Omega Funds, GV, Two River, Polaris Partners, The Invus Group, Vida Ventures, LLC and Perceptive Advisors

K

Kronos Bio raised $18M on June 5, 2018

Investors: Bellco Capital, Omega Funds and Vida Ventures, LLC

FAQ